http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6642211-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_07c9542186133097bd6bbb7d92393090 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53 |
| filingDate | 2002-04-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2003-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe2236ac7fb4e52d51bcbef41dd00dc4 |
| publicationDate | 2003-11-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-6642211-B2 |
| titleOfInvention | Treatment of cancer with thymidine in combination with temozolamide |
| abstract | Methods for treating cancer are provided that involve administration of a combination of the chemotherapeutic drug, temozolamide, and thymidine. |
| priorityDate | 2001-04-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 62.